Archive

FOIA to Multiple Agencies Seeking Coronavirus Intelligence Products

April 1, 2020
FOIA request the Office of the Director of National Intelligence, Department of Homeland Security, Department of State, Defense Intelligence Agency, and Central Intelligence Agency seeking all finished intelligence products regarding the coronavirus outbreak and the risk of its spread.

FOIA to NIAID Seeking Any Directives Relating to Media Appearances by Dr. Anthony Fauci

March 31, 2020
FOIA request to the National Institute of Allergy and Infectious Disease (NIAID) seeking any directive, order, or guidance requiring or advising Dr. Anthony Fauci to cancel or decline media appearances, or directing him to convey specific messages or content during media appearances.

‘We Are Flying Blind’: Health Officials’ Late February Emails Show Rising Coronavirus Concerns

March 30, 2020
New emails show senior health officials were increasingly alarmed about coronavirus in late February, even as Trump and others were publicly downplaying the threat.

FOIA to OMB Seeking Communications Regarding Companies Developing Vaccines or Treatments for Coronavirus

March 27, 2020
FOIA to the Office of Management and Budget seeking communications regarding companies developing vaccines or treatments for coronavirus.

FOIA to FDA Seeking Records Sufficient to Identify Date Gilead Submitted Orphan Drug Designation Request for COVID-19 Treatment

March 27, 2020
FOIA to the Food and Drug Administration (FDA) seeking records sufficient to identify the date Gilead submitted its request for orphan-drug designation for remdesivir as a treatment for COVID-19.

FOIA to HHS Seeking Communications with Companies Developing Vaccines or Treatments for Coronavirus

March 27, 2020
FOIA to the U.S. Department of Health and Human Services (HHS) seeking communications with companies developing vaccines or treatments for coronavirus.

FOIA to FDA Seeking Records Related to Orphan-Drug Designation Requests for COVID-19 Treatments

March 27, 2020
FOIA to the Food and Drug Administration seeking records sufficient to identify, with respect to requests for orphan-drug designation for treatments for COVID-19, the requester’s name, the date of the request, and the name of the treatment.